Assessment for effect and safety of Tenofovir Disoproxil Fumarate Tablets in the treatment of hepatitis B: a randomized, double blinding by double simulation, positive agent, multicenter trial
Phase of Trial: Phase III
Latest Information Update: 24 Apr 2016
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary) ; Adefovir dipivoxil
- Indications Hepatitis B
- Focus Therapeutic Use
- 29 Jul 2014 Status changed from not yet recruiting to completed as reported by Chinese Clinical Trial Register.
- 21 May 2012 Planned end date (Nov 2012) added as reported by Chinese Clinical Trial Register.
- 21 May 2012 Planned initiation date changed from 1 Mar 2010 to 1 Mar 2012 as reported by Chinese Clinical Trial Register.